While traditional methods including patient education, rest, exercise, anti inflammatory drugs, injections, and physical therapy offer temporizing measures, there is still the requirement for a better solution. This is a normally felt to be an illness of cartilage. However, osteoarthritis is a complex illness that appears to involve a complex series of pathways that include abasement of cartilage, inflammation of the lining of the joint (synovium), and stimulant of pain pathways through various chemical messenger systems.
The goals for managing hip osteoarthritis treatment and knee are to decrease pain and restore or keep function. A third and even more palling task is to rectify new cartilage. There is exciting new growth in this region. The results of a two year study of osteoarthritis of the knee assessing the security and efficacy of orthokine therapy was published in the July August 2008 issue of Osteoarthritis and Cartilage.
Orthokine is a content derived from a patient s own blood. Orthokine evidently has important anti inflammatory impacts. This material is then put in into the osteoarthritis joint. This is believed best treatment for osteoarthritis.
The number of patients needing further treatment was least in the orthokine group. Two years after treatment, amendment was still measurable in all three groups. A clear variation was seen, however, in scores on the WOMAC, a form that is utilized in osteoarthritis clinical trials to measure joint function and lineament of life.
The orthokine treated patients scored 58 on the two year follow up WOMAC, while the hyaluronic acid and placebo groups scored higher at 88 and 84 respectively. Another measure called the visual analog scale (VAS) that measures pain from 0 (no pain) to 100 (most intense pain imaginable), was also used. The average pain level prior to treatment was 70 in all groups.
What is interesting about this research is how well placebo did relate with both hyaluronic acid as well as orthokine in alleviating pain in hip osteoarthritis treatment. Experienced clinicians have known for decades that there is a important placebo effect in just using a needle when it comes to immanent measures such as pain relief.
For osteoarthritis, they have found that connecting autologous stem cells – got from bone marrow drew out from the pelvic bone of the patient utilizing local anesthetic and platelet rich plasma looks to be an efficient treatment for the knee and hip. Both the stem cells as well as the platelet rich plasma are injected into the osteoarthritis joint. This combining hip osteoarthritis treatment not only aids in pain alleviate but there also looks to be stimulation of cartilage regeneration.
Copyright © www.orthopaedics.win Bone Health All Rights Reserved